Store lyophilised GSH at -20 C, sealed and protected from light and moisture - the cysteine thiol is highly susceptible to oxidation
Figure 1: A metabolic use-case comprehensive patient journey view with taXonomy Pathways In clinical trials, GLP-1 drugs showed high adherence (over 85% of patients stayed on therapy), yet real-world use tells a different story: one large study found only 32% of obese patients remained on a GLP-1 therapy after one year, with just 27% meeting standard adherence thresholds
The dedicated eating-disorder flow is especially notable because rapid weight-loss treatment can be inappropriate for some patients even if they technically meet a BMI threshold
Tirzepatide may reduce the effectiveness of oral contraceptives during dose initiation or escalation, requiring additional contraceptive methods during these periods
It has to be done responsibly
By constantly signaling to the brain that the body is full, peristalsis (rippling GI waves that push contents through the gut) is slowed, thereby disrupting the bodys natural digestion process. According to Fereday: The anecdotes of the early adopters are not necessarily that representative of how things will play out if this class of drugs goes mainstream